A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor

被引:348
作者
Ratner, Nancy [1 ]
Miller, Shyra J. [1 ]
机构
[1] Cincinnati Childrens Hosp, Canc & Blood Dis Inst, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA
基金
美国国家卫生研究院;
关键词
NERVE SHEATH TUMOR; GASTROINTESTINAL STROMAL TUMORS; INTEGRATED GENOMIC ANALYSIS; RAS SIGNALING PATHWAY; OF-FUNCTION MUTATIONS; SOFT-TISSUE SARCOMA; SOUTH EAST WALES; SCHWANN-CELLS; NF1; LOSS; VONRECKLINGHAUSEN NEUROFIBROMATOSIS;
D O I
10.1038/nrc3911
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Neurofibromatosis type 1 (NF1) is a common genetic disorder that predisposes affected individuals to tumours. The NF1 gene encodes a RAS GTPase-activating protein called neurofibromin and is one of several genes that (when mutant) affect RAS-MAPK signalling, causing related diseases collectively known as RASopathies. Several RASopathies, beyond NF1, are cancer predisposition syndromes. Somatic NF1 mutations also occur in 5-10% of human sporadic cancers and may contribute to resistance to therapy. To highlight areas for investigation in RASopathies and sporadic tumours with NF1 mutations, we summarize current knowledge of NF1 disease, the NF1 gene and neurofibromin, neurofibromin signalling pathways and recent developments in NF1 therapeutics.
引用
收藏
页码:290 / 301
页数:12
相关论文
共 208 条
[61]   Neurofibromatosis type 1 - Motor and cognitive function and T2-weighted MRI hyperintensities [J].
Feldmann, R ;
Denecke, J ;
Grenzebach, M ;
Schuierer, G ;
Weglage, J .
NEUROLOGY, 2003, 61 (12) :1725-1728
[62]   Guidelines for the diagnosis and management of individuals with neurofibromatosis 1 [J].
Ferner, Rosalie E. ;
Huson, Susan M. ;
Thomas, Nick ;
Moss, Celia ;
Willshaw, Harry ;
Evans, D. Gareth ;
Upadhyaya, Meena ;
Towers, Richard ;
Gleeson, Michael ;
Steiger, Christine ;
Kirby, Amanda .
JOURNAL OF MEDICAL GENETICS, 2007, 44 (02) :81-88
[63]   Activating mutations in RRAS underlie a phenotype within the RASopathy spectrum and contribute to leukaemogenesis [J].
Flex, Elisabetta ;
Jaiswal, Mamta ;
Pantaleoni, Francesca ;
Martinelli, Simone ;
Strullu, Marion ;
Fansa, Eyad K. ;
Caye, Aurelie ;
De Luca, Alessandro ;
Lepri, Francesca ;
Dvorsky, Radovan ;
Pannone, Luca ;
Paolacci, Stefano ;
Zhang, Si-Cai ;
Fodale, Valentina ;
Bocchinfuso, Gianfranco ;
Rossi, Cesare ;
Burkitt-Wright, Emma M. M. ;
Farrotti, Andrea ;
Stellacci, Emilia ;
Cecchetti, Serena ;
Ferese, Rosangela ;
Bottero, Lisabianca ;
Castro, Silvana ;
Fenneteau, Odile ;
Brethon, Benoit ;
Sanchez, Massimo ;
Roberts, Amy E. ;
Yntema, Helger G. ;
Van der Burgt, Ineke ;
Cianci, Paola ;
Bondeson, Marie-Louise ;
Digilio, Maria Cristina ;
Zampino, Giuseppe ;
Kerr, Bronwyn ;
Aoki, Yoko ;
Loh, Mignon L. ;
Palleschi, Antonio ;
Di Schiavi, Elia ;
Care, Alessandra ;
Selicorni, Angelo ;
Dallapiccola, Bruno ;
Cirstea, Ion C. ;
Stella, Lorenzo ;
Zenker, Martin ;
Gelb, Bruce D. ;
Cave, Helene ;
Ahmadian, Mohammad R. ;
Tartaglia, Marco .
HUMAN MOLECULAR GENETICS, 2014, 23 (16) :4315-4327
[64]   Cardiovascular disease in neurofibromatosis 1: Report of the NF1 cardiovascular task force [J].
Friedman, JM ;
Arbiser, J ;
Epstein, JA ;
Gutmann, DH ;
Huot, SJ ;
Lin, AE ;
McManus, B ;
Korf, BR .
GENETICS IN MEDICINE, 2002, 4 (03) :105-111
[65]  
Friedman JM, 1997, AM J MED GENET, V70, P138, DOI 10.1002/(SICI)1096-8628(19970516)70:2<138::AID-AJMG7>3.0.CO
[66]  
2-U
[67]   Autism and other psychiatric comorbidity in neurofibromatosis type 1: evidence from a population-based study [J].
Garg, Shruti ;
Lehtonen, Annukka ;
Huson, Susan M. ;
Emsley, Richard ;
Trump, Dorothy ;
Evans, D. Gareth ;
Green, Jonathan .
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2013, 55 (02) :139-145
[68]   The Receptor Tyrosine Kinase Alk Controls Neurofibromin Functions in Drosophila Growth and Learning [J].
Gouzi, Jean Y. ;
Moressis, Anastasios ;
Walker, James A. ;
Apostolopoulou, Anthi A. ;
Palmer, Ruth H. ;
Bernards, Andre ;
Skoulakis, Efthimios M. C. .
PLOS GENETICS, 2011, 7 (09)
[69]   Requirement of Drosophila NF1 for activation of adenylyl cyclase by PACAP38-like neuropeptides [J].
Guo, HF ;
The, I ;
Hannan, F ;
Bernards, A ;
Zhong, Y .
SCIENCE, 1997, 276 (5313) :795-798
[70]   Optimizing biologically targeted clinical trials for neurofibromatosis [J].
Gutmann, David H. ;
Blakeley, Jaishri O. ;
Korf, Bruce R. ;
Packer, Roger J. .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2013, 22 (04) :443-462